CompletedPhase 4

Nd-YAG Laser Versus Epidermal Growth Factor For Myogenic Tempromandibular Disorder.

Egypt29 participantsStarted 2023-01-21

Plain-language summary

A clinical trial comparing the potential effect of 2 different modalities (Nd-YAG Laser Versus Epidermal growth factor injection) on pain reduction in patients suffering from myogenic tempromandibular disorder.

Who can participate

Age range20 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients, both males and females, 20 years and older will be included in this clinical trial.
✓. Patients suffering from myogenic TMD (myogenic TMD/ Myofascial pain without referral/ Myofascial pain with referral) based on Diagnostic criteria for diagnosis of Tempromandibular joint disorders (DC/TMD) criteria (1)
✓. Patients suffering of unilateral or bilateral chronic pain (\> 3 months duration) related to masseter and temporalis muscles (29)
✓. Patients that have not responded to conservative modes of treatment (analgesics, muscle relaxants, fomentation, splints ect.).

What they're measuring

Pain Score (Numerical Rating Scale)

Timeframe: Pain will be measured at baseline, 7,14,21 days, and 4, 12 weeks.

Trial details

NCT IDNCT06044974

SponsorAlexandria University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-08-10

View on ClinicalTrials.gov More Temporomandibular Joint Disorders trials